Portfolio Lab

Omnicell, Inc.

  • Stock
  • Ticker OMCL
  • ISIN US68213N1090
  • Nasdaq

Technology · Computers and communications equipment · USA

$32.51 −2.02%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Omnicell, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

OMCLGlobal equities (VT)

$10,000 grew to $9,315. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −86.6% in 05/2025, measured from the peak in 11/2021. The old peak has not been reached again yet.

1-year return
−5.3%
5-year return p.a.
−29.2%
10-year return p.a.
−0.7%
Volatility p.a.
41.9%
Largest decline
−86.6%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue307270291311314310312308
Gross profit142111128135130140153138
Operating income12-128.18.20.4173215
EBITDA328.4282820355133
Net income16-7.05.65.5-2.0112411
Earnings per share0.34-0.150.120.12-0.050.250.520.24
Balance sheet
Total assets2,1212,1512,1451,9491,9752,0041,9992,057
Liabilities878894882728743747707740
Equity1,2431,2571,2641,2211,2321,2571,2921,317
Cash369387399180197239292315
Cash flow
Operating cash flow5626432830556833
Capital expenditure-9.1-11-12-9.8-7.7-12-8.9-11
Free cash flow4715311923425922

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2021 at +50.3%, weakest 2022 at −72.1%. 7 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
4 Nov 2026$0.24
5 Aug 2026$0.52
6 May 2026$0.25
26 Feb 2026−$0.05
5 Nov 2025$0.12
6 Aug 2025$0.12
7 May 2025−$0.15
27 Feb 2025$0.34
8 Nov 2024$0.19
6 Aug 2024$0.08
7 May 2024−$0.34
28 Feb 2024−$0.32

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€1.4bn
Market cap in trading currency
$1.50bn
Enterprise value
$1.18bn
P/E
33.9
P/S
1.20
P/B
1.14
EV/Sales
0.95
EV/EBITDA
8.4
Earnings yield
3.0%
FCF yield
9.7%

Results (last four quarters)

Revenue
$1.24bn
Gross profit
$561m
EBITDA
$140m
Net income
$44.7m
Earnings per share
$0.96
Revenue per share
$27.04
Revenue growth
−0.9%
Earnings growth
+102.2%

Profitability

Gross margin
45.1%
Operating margin
5.2%
Net margin
3.6%
Return on equity
3.5%
Return on assets
2.2%

Balance sheet and cash flow

Cash
$315m
Cash per share
$6.85
Financial debt
–
Debt/equity %
–
Current ratio
1.66
Book value per share
$28.64
Operating cash flow
$186m
Free cash flow
$146m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
46.0m
Volume
564,519
Avg. volume 3 months
579,443
Relative volume
1.0

Price and technicals

Price
$32.51
1 day
−2.0%
52-week high
$51.39
52-week low
$32.23
Distance to 52-week high
−36.7%
Distance to 52-week low
+0.9%
Distance to 50-day line
−7.4%
Distance to 200-day line
−14.6%
RSI (14)
36
Volatility 1M
51.6%

Performance

1 week
−7.2%
1 month
−12.4%
3 months
−6.2%
6 months
−26.8%
YTD
−28.2%
1 year
−5.8%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has OMCL performed since 11/2016?

$10,000 grew to $9,315 by 20 Nov 2026, which is −0.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is OMCL?

Volatility was 41.9% per year, measured on monthly returns. The largest decline from a peak was −86.6%, with the low in 05/2025.

How does OMCL compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, OMCL returned −0.7% at 41.9%. The correlation of monthly returns was 0.36; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Omnicell, Inc. (OMCL): Return and risk | Portfolio Lab